Alterity Therapeutics to Present New Data on ATH434 at the
MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”),...
Source: globenewswire.com
Synuclein Aggregation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Synuclein Aggregation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Synuclein Aggregation Today - Breaking & Trending Today
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...
Source: marketscreener.com
Alterity Therapeutics to Present New Data at the Upcoming
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference – – Baseline Biomarker Data to...
Source: globenewswire.com
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference – – Baseline Biomarker Data to be Presented from Ongoing ATH434-201...
Source: marketscreener.com
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 ...
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference –
Source: eagletribune.com